Better Therapeutics Stock (OTC:BTTX), Analyst Ratings, Price Targets, Predictions

The latest price target for Better Therapeutics (OTCPK: BTTX) was reported by Lake Street on August 10, 2023. The analyst firm set a price target for $3.00 expecting BTTX to rise to within 12 months (a possible 23880.82% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Better Therapeutics (OTCPK: BTTX) was provided by Lake Street, and Better Therapeutics maintained their buy rating.

There is no last upgrade for Better Therapeutics.

There is no last downgrade for Better Therapeutics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Better Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Better Therapeutics was filed on August 10, 2023 so you should expect the next rating to be made available sometime around August 10, 2024.

While ratings are subjective and will change, the latest Better Therapeutics (BTTX) rating was a maintained with a price target of $5.00 to $3.00. The current price Better Therapeutics (BTTX) is trading at is $0.01, which is out of the analyst’s predicted range.